Catheter Precision, Inc. (NYSE: VTAK), a U.S.-based medical device company specializing in advanced solutions for the cardiac electrophysiology market, announced today that the LockeT Compare Study has officially begun enrolling patients. The first three participants have already joined the study, marking a significant step forward in evaluating the company’s suture retention technology.
The LockeT Compare Study is a single-center, physician-initiated trial that aims to enroll up to 100 patients. Its primary objective is to assess the safety profile of the LockeT suture retention device against internal closure devices. Post-catheterization groin complications, which can range from minor bruising to serious events such as embolism, remain a notable concern following cardiac catheter procedures.
Early clinical data on the LockeT device has demonstrated that it is safe, effective, and reduces procedural costs while seamlessly integrating into existing hospital workflows. The Compare Study is designed to build upon this evidence by further evaluating outcomes and safety benefits.
“Effective groin management at the access site after a cardiac catheter procedure, is just as important as the procedure outcomes,” said David Jenkins, CEO of Catheter Precision. “We have successfully shown that LockeT creates hemostasis as an external device and believe that this study will also show that there is a reduction in thrombotic episodes compared to closure devices that have an internal closure mechanism, thus improving patient safety.”
With enrollment now underway, Catheter Precision is advancing its mission to provide innovative solutions that address critical unmet needs in cardiac electrophysiology, with LockeT positioned as a differentiated approach to vascular closure management.
About Catheter Precision
Catheter Precision is an innovative U.S.-based medical device company bringing new solutions to market to improve the treatment of cardiac arrhythmias. It is focused on developing groundbreaking technology for electrophysiology procedures by collaborating with physicians and continuously advancing its products.
This article contains sponsored content. Please see our disclaimer at: https://prismmarketview.com/disclaimer/
The post Catheter Precision Begins Enrollment for LockeT Compare Study appeared first on PRISM MarketView.
